Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • November 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Medec Dragon Pvt Limited Conferred Best Pharmaceutical Company 2021 at European Business Awards 2021
    Business

    Medec Dragon Pvt Limited Conferred Best Pharmaceutical Company 2021 at European Business Awards 2021

    By January 25, 2022No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), January 25: Medec Dragon Pvt Limited , One of India’s Leading manufacturers and exporter of Anti Cancer and Anti Malarial Drugs, was Awarded The “ Best Pharmaceutical Company of the Year 2021 “ by European Business Assembly. Dr Deepak Shenoy Promoter and Managing Director, received the award on behalf of the company.

    Medec Dragon Pvt Limited received the recognition because of the forward-looking approach of the company with the risk-taking abilities in the current tough situations at a time when Pharma industry is facing a tough task in pricing, clinical trials hurdles & regulatory approvals. The company Exports to over 75 countries globally.

    The company provides anti-malarial, expectorant, emetic, CNS, anti retro-viral, ace inhibitor, erectile dysfunction, animal health, anti-cancer, and diabetic APIs, as well as pain management products. It also offers formulations, such as finished antimalarial dosages, animal health products, anti TB drug therapy products, expectorants/cold preparations/mucolytic, lozenges, multivitamin syrups, analgesics, anti-obesity products, erectile dysfunction and hormone replacement therapy products, and topicals.

    “This Award recognizes Medec Dragon Pvt Limited ability to stay ahead in competition”, said  Dr  Deepak Shenoy, Managing Director, while receiving the coveted recognitions.  Medec Dragon Pvt Limited will look at the new year with increased technology innovations & wider market access added by Dr Deepak Shenoy while addressing the 300 strong veterans of the Pharma Industry present at the Awards Ceremony.

    The European Business Assembly, in collaboration with Oxford Union, also conferred Honorary Doctorate in Business Administration to Dr Deepak Shenoy to honour him for his consistent efforts to export lifesaving drugs to emerging Markets.

    Accepting the Award Dr Deepak Shenoy commented, “I am extremely honoured to receive this Honorary Doctorate from a  University that plays such an important role in developing the potential and talent of tens of thousands of students from all over the world. May you all be fortunate enough to know someone who will inspire you to feel the joy and satisfaction that comes from helping others.”

    Website: www.medecdragon.com

    To Know More About Him, Please do watch https://youtu.be/kPM1GUeycSA

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Duroply Showcases its Built-to-Last Legacy

    November 14, 2026

    Austere Systems Announces H1 FY27 Results

    November 14, 2026

    ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27

    November 14, 2026

    Comments are closed.

    Recent Post
    • Duroply Showcases its Built-to-Last Legacy
    • Austere Systems Announces H1 FY27 Results
    • ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27
    • PAN HR Solution Limited Reports H1 FY27 Results
    • Why Colonialism Still Matters: Museum of British Colonialism to Host Online Panel Discussion on 19 November
    • Dr. R. K. Thukral and the Work of Bringing Neuropsychiatry Closer to Patients
    • From Global Recognition to Academic Excellence: LBSIM’s Continuing Journey After AACSB Accreditation
    • DEV Information Technology Reports Q2 FY27 Total Income of Rs. 63.07 Cr, Up 28 Percent YoY; H1 FY27 Total Income Reaches Rs. 107.72 Cr, Up 16 Percent YoY

    Type above and press Enter to search. Press Esc to cancel.